Dr. Vakil Takhaveev is a Lecturer at ETH Zurich's Department of Health Sciences and Technology, within the Institute of Food, Nutrition and Health. His research focuses on DNA damage mechanisms, aging, cancer, and neurodegeneration, with particular emphasis on developing novel DNA-damage-sequencing methods like click-code-seq and TRABI-Seq . He investigates anticancer drug action (e.g., trabectedin), aging clocks using DNA oxidation profiling, and stress-induced carcinogenesis. His work integrates multi-omics approaches and advanced sequencing techniques. Research Directions: Novel DNA-Damage-Sequencing Methods: Developed click-code-seq and TRABI-Seq for genomic mapping of DNA lesions and repair dynamics. Anticancer Drug Action: Explored mechanisms of trabectedin and other chemotherapeutics, linking DNA repair vulnerabilities to therapy resistance. Aging Clocks: Created DNA oxidation-based biomarkers for biological aging using genome-wide profiling in human and mouse models. Stress-Induced Pathologies: Studies metabolic and DNA damage links to early tumorigenesis and neurodegeneration. Awards & Recognition: 2025 Public Award Winner in PIs of Tomorrow competition 2024 ETH Zurich Career Seed Award Best presentation awards (Swiss Chemical Society, American Chemical Society) Grants & Collaborations: Impetus grants for aging clock development Swiss Chemical Society and American Chemical Society fellowships Labs & Teams: Leads research on DNA damage and aging mechanisms at ETH Zurich, collaborating with international groups in oncology and toxicology.
David H. Sherman is the Hans W. Vahlteich Professor of Medicinal Chemistry at the University of Michigan, holding joint appointments in the College of Pharmacy (Department of Medicinal Chemistry), Medical School (Microbiology & Immunology), and College of Literature, Science, and the Arts (Chemistry). He leads the Sherman Lab at the Life Sciences Institute and co-founded the Natural Products Discovery Core. His research focuses on natural product discovery, biosynthetic pathways, and drug development for infectious diseases, cancer, and neurological disorders. Education: PhD in Synthetic Organic Chemistry from Columbia University (1981), BA in Chemistry from UC Santa Cruz (1978). Postdoctoral research at MIT (1984). Research interests include microbial secondary metabolites, enzymatic catalysis (e.g., C-H functionalization, polyketide assembly), and high-throughput drug screening. He pioneered a microbial natural product library with over 50,000 samples. Current projects emphasize developing macrolide antibiotics and advancing compounds toward clinical trials through the Natural Products Biosciences Initiative. Collaborations span global institutions, with a focus on biodiversity conservation and capacity-building in low-income nations. He has mentored 67 PhD students, 60 postdocs, and 85+ undergraduates, fostering interdisciplinary training in chemical biology and microbial biochemistry. Labs/Teams: Sherman Lab (Life Sciences Institute), Center Member at Samuel and Jean Frankel Cardiovascular Center, Center for Computational Medicine and Bioinformatics, Rogel Cancer Center.
Min Hu is an Assistant Professor in the Department of Economics, Philosophy, and Political Science at the University of British Columbia, Okanagan Campus. He holds an adjunct position at Dalhousie University's School of Health Administration. His primary research focuses on Health Economics, Applied Microeconomics, and Labour Economics, with an emphasis on vulnerable populations in Canada, Indigenous health, income inequalities, and cancer economics. He teaches courses in Microeconomics, Health Economics, and Statistics. Education: PhD in Economics (2019), Dalhousie University; Postdoctoral Fellowship in Health Economics (2019–2020), Dalhousie University. Previous degrees include an M.A. (2014–2016) and B.A. in Economics from Dalhousie University. Research interests include the socio-economic determinants of health disparities, particularly among Indigenous peoples and immigrants, and the economic impacts of cancer-related policies. He employs applied econometric methods to analyze labor market outcomes and social policy effectiveness. His recent articles explore sustainable biomass utilization, energy policies, and environmental engineering innovations. Key themes include biomass supply chain optimization, CO₂ reduction strategies, and waste-to-energy technologies. Scientific Awards: Recipient of SSHRC New Frontiers Grant (2023–2026), CIHR Team Grant (2024–2026), and multiple UBC startup grants. His work is supported by SSHRC, CRDCN, and Indigenous Services Canada. He advises students in Economics and Global Studies (IGS) programs. Grants and funding span health economics, Indigenous well-being, and sustainable energy systems. Collaborations include interdisciplinary teams in health administration and environmental policy. Labs/Teams: Engaged with UBC's Okanagan Sustainability Initiatives and Dalhousie's Health Economics Research Group. Affiliated with professional organizations like the American Economic Association and Canadian Health Economics Study Group.
David John Procter is a Professor of Organic Chemistry and Head of the Department of Chemistry at the University of Manchester. His career includes academic roles at the University of Glasgow (Lecturer, Senior Lecturer) and a Readership at the University of Manchester, where he became a Professor in 2008. His research focuses on developing new synthetic methods, catalysis, and materials chemistry, with applications in drug discovery, biocatalysis, and organic electronics. Education: BSc Chemistry (University of Leeds, 1992), PhD (1995, supervised by Prof. Christopher Rayner). Postdoctoral work: Florida State University (Prof. Robert Holton, Taxol analog synthesis). Research interests include samarium diiodide-mediated reactions, metal-free coupling processes, and sustainable synthesis methods. He leads projects funded by EPSRC, Industry (30 grants), and international collaborations. Awards include the EPSRC Established Career Fellowship (2015–2020), Bader Prize (2014), and Young Heterocyclic Chemist Award (2015). Key contributions: Total synthesis of natural products (e.g., pleuromutilin), development of copper-catalyzed multicomponent couplings, and innovative methods for organic materials. His work aligns with UN Sustainable Development Goals related to affordable and clean energy and responsible consumption. Collaborations span academic and industrial partnerships in chemistry, physics, and biology. He supervises 60+ students and contributes to the Organic Materials Innovation Centre (OMIC). His group’s research is detailed at proctergroupresearch.com .
Professor Scott Sisson is Director of the UNSW Data Science Hub (uDASH) and Professor of Statistics and Data Science at the University of New South Wales, School of Mathematics and Statistics. His research focuses on computational statistics, particularly solving 'intractable' statistical problems through Bayesian methods, big data techniques, simulation algorithms, and extreme value theory with environmental applications. Education includes a PhD in Statistics from Bristol University (2002), MSc in Environmental Statistics from Lancaster University (1997), and BSc in Mathematics and Statistics from Lancaster University (1996). Research interests span: Bayesian statistics and uncertainty quantification Big data analytics and scalable algorithms Machine learning integration with statistical methods Extreme value modeling for climate/environment Computational techniques for intractable problems Recent publications (2022-2025) demonstrate strong emphasis on Bayesian computation, spatiotemporal modeling, and interdisciplinary applications in materials science, oncology, quantum computing, transportation policy, and ecology. Methodological innovations include likelihood-free inference, modular Bayesian analyses, and symbolic data modeling. Awards and honors: 2020 Service Award (Statistical Society of Australia) 2017 ARC Future Fellowship 2015 G. N. Alexander Medal (Engineers Australia) 2011 Moran Medal (Australian Academy of Science) 2010 J.G. Russell Award (Australian Academy of Science) 2010 Queen Elizabeth II Research Fellowship As Director of uDASH, he leads data science initiatives across UNSW. He maintains sustained ARC funding and supervises students in computational statistics, Bayesian methods, extreme value theory, and machine learning. Professional service includes editorial roles for Statistics and Computing and past presidency of Statistical Society of Australia.
Rainer Haag is a Professor at the Department of Chemistry, Freie Universität Berlin, leading the Haag Group in the Institute of Chemistry and Biochemistry. His research focuses on biodegradable and sustainable materials, dynamic hydrogels, and polymeric nanosystems for biomedical applications. Department of Chemistry, Freie Universität Berlin Member of SFB 1449: Dynamic Hydrogels at Biointerfaces Collaborator in the StemGel startup project Co-founder of CSR|Berlin interdisciplinary research institute Research Interests: Development of stimuli-responsive polymers, multivalent virus inhibitors, and functional biointerfaces. Key projects include: Antiviral coatings using heteromultivalent polymers Thermoresponsive hydrogels for stem cell expansion Graphene derivatives for bacterial capture and disinfection Lignin upcycling for sustainable resin materials Supramolecular nanosystems for drug delivery Publication Trends highlight interdisciplinary work in polymer chemistry, nanotechnology, and biomedical applications. Recent articles focus on: 2D polyglycerols for virus interactions Redox-responsive nanogels Mucus-inspired adhesive hydrogels Tumor-targeting micelles Bacterial disinfection using graphene composites Labs & Collaborations include the Polymeric and Supramolecular Nanosystems subgroup, the Dynamic Hydrogels and Biointerfaces team, and partnerships with MIT in developing bioinspired adhesives. His group contributes to DFG-funded SFB 1449 and CSR|Berlin initiatives.
Jacky Bourgeois is an Assistant Professor of Data-Centric Design at Delft University of Technology's Faculty of Industrial Design Engineering (IDE), leading the Data-Centric Delft Design Lab. His work bridges Human-Computer Interaction, Data Science, and Participatory Design, focusing on methods like data donation to empower collaborative data exploration. He holds a computer science background, previously researching ubiquitous technologies for domestic energy practices of 'energy farmers' (solar households). Key projects include the PROMISE study on patient-led oncological care and the Data Donation initiative promoting ethical data practices. Education: Background in Computer Science; academic focus on sustainable design engineering and IoT. Teaching includes courses like 'Data-Centric Design for...' (2024) and 'Digital Product Development' (2023). Research Interests: Data as subjective inquiry material, data intimacy, data commons, and human-data interaction in home contexts. Notable contributions include PAIRcolator for collaborative data reflection and Tangi for 360° video insights. Awards include Best Paper at CHI 2025 and DIS '24 Best Paper. Grants & Collaborations: NWO-funded research on hospital sounds (2024), IoT Rapid Proto Labs for industry-academia partnerships, and ancillary role as a scientific employee at The Open University (2025–2027). Labs & Teams: Director of the Data-Centric Delft Design Lab; collaborates with the HCI Data & Design SIG. Current projects address ethical frameworks for data donation and patient-centered healthcare systems.
Prof. Paul Stupple is a Professor of Medicinal Chemistry at Monash University, Australia, with over 20 years' experience in pharmaceutical industry and academia. He holds leadership roles at Canthera Discovery and manages the Australian Translational Medicinal Chemistry Facility. His expertise lies in small molecule drug discovery, particularly targeting cancer therapies and epigenetic regulators. Affiliations: Monash University, Faculty of Pharmacy and Pharmaceutical Sciences Canthera Discovery (Director, Medicinal Chemistry) Education: BA and DPhil in Chemistry from the University of Oxford (1992–1999). Early career at Pfizer as a medicinal chemistry leader, delivering 6 clinical candidates. Key contributions include: Licensing deals with Merck (2016) and Pfizer (2018) for preclinical projects Leading the Cancer Therapeutics CRC's medicinal chemistry program Research Interests: Small molecule drug discovery focused on histone acetyltransferase inhibitors, cancer therapeutics, and epigenetic modulation. Notable projects include development of KAT6A/B inhibitors for ER+ breast cancer and STING agonists for immunotherapy. Grants/Projects: Principal Investigator for major initiatives like MedChem Australia (2023–2028) and drug target identification platforms. Collaborates widely with institutions like WEHI and University of Sydney. Over 28 peer-reviewed publications spanning 1997–2025. Labs/Teams: Oversees the Australian Translational Medicinal Chemistry Facility, a key resource for drug discovery in Australia.
John Paisley is an Associate Professor of Electrical Engineering at Columbia University's Fu Foundation School of Engineering and Applied Science, and a member of Columbia's Data Science Institute (DSI). He holds a B.S., M.S., and Ph.D. in Electrical and Computer Engineering from Duke University (2004-2010), followed by postdoctoral research in Computer Science at Princeton University and UC Berkeley. His research focuses on Bayesian models, posterior inference techniques for Big Data, and applications in data analysis, recommendation systems, information retrieval, and compressed sensing. He has pioneered methods like Bayesian Gaussian Process ODEs and Double Normalizing Flows, with recent work emphasizing uncertainty quantification in environmental modeling and neuroimaging analysis. His collaborative workflows (e.g., bneR ) address air pollution exposure and PM2.5 concentration uncertainties, combining Bayesian nonparametric ensembles with geospatial data. He has also developed frameworks for neural network interpretability, image denoising, and compressed sensing MRI. Paisley's work bridges statistical theory and applied machine learning, with applications in healthcare, environmental science, and geophysics. His academic contributions include over 50 publications since 2016, spanning topics like deep metric learning, adversarial learning, and variational inference optimization. He maintains an active research group and serves on editorial boards for machine learning and signal processing journals.
Weiping Tang is a Professor of Pharmaceutical Sciences and Chemistry at the University of Wisconsin-Madison, holding the Janis Apinis Professorship in the School of Pharmacy and the Vilas Distinguished Achievement Professorship. He also serves as Director of the Medicinal Chemistry Center at the School of Pharmacy and maintains a faculty appointment with the Department of Chemistry in the College of Letters and Science. Janis Apinis Professor of Pharmaceutical Sciences Vilas Distinguished Achievement Professor Director of Medicinal Chemistry Center Faculty Appointment with Department of Chemistry Dr. Tang received his B.S. in Chemistry from Peking University in 1997, M.S. in Chemistry from New York University in 1999, Ph.D. in Organic Chemistry from Stanford University in 2005, and completed a postdoctoral fellowship in Medicinal Chemistry, Chemical Biology and Drug Discovery at Harvard University in 2007. Dr. Tang's research program focuses on drug discovery for cancer, infectious diseases, and neurodegenerative disorders through three interconnected areas: Organic Synthesis (advancing glycoscience through novel carbohydrate synthesis technologies), Medicinal Chemistry (developing small molecules that selectively remove disease-associated proteins), and Chemical Biology (dissecting biological pathways using novel small molecule probes). His group operates as an interdisciplinary team where chemists and biologists collaborate closely on drug discovery projects, with particular emphasis on developing novel degraders for disease-causing proteins. Analysis of Dr. Tang's publication record reveals a significant shift toward targeted protein degradation technologies, particularly PROTACs and molecular glues, while maintaining strong foundations in carbohydrate chemistry. His most impactful recent work includes developing degraders for extracellular and membrane proteins (previously considered 'undruggable'), creating rapid synthesis platforms like Rapid-TAC and Rapid-Glue, and advancing understanding of ternary complex formation for novel PROTAC design. His research spans both chemical methodology development and therapeutic applications across multiple disease areas. Vilas Distinguished Achievement Professorship Janis Apinis Professorship Numerous high-impact publications in leading chemistry and pharmacology journals Editor's pick and hot paper designations for significant contributions Dr. Tang mentors a diverse team of graduate students, postdoctoral fellows, and staff scientists with expertise spanning synthetic chemistry, medicinal chemistry, carbohydrate chemistry, computational chemistry, biochemistry, and cell biology. His group has developed innovative platforms for the rapid synthesis of protein degraders and has made significant contributions to understanding the mechanisms of action for these novel therapeutics. Current research includes developing selective degraders for cancer targets like RIPK1, BRD4, and CARM1, as well as advancing delivery systems for clinical translation. The Tang Research Group maintains state-of-the-art facilities within the School of Pharmacy at UW-Madison, equipped for comprehensive chemical synthesis, compound characterization, and biological evaluation. The group actively collaborates with researchers across campus and with industry partners to advance discoveries toward clinical applications, with particular focus on cancer therapeutics and protein degradation technologies.
Affiliation & Education Scott Hauck is a Professor at the University of Washington's Department of Electrical & Computer Engineering and an Adjunct Professor in Computer Science & Engineering. He leads the Adaptive Computing Machines and Emulators (ACME) Lab . He earned his BS in EECS from UC Berkeley (1990), and MS/PhD in CSE from the University of Washington (1992/1995). Research Focus Dr. Hauck specializes in FPGA-based reconfigurable computing with applications in: Quantum Computing: FPGA controllers for trapped-ion quantum systems enabling precise laser control and quantum state readout. Medical Imaging: Portable radiation sensors for personalized cancer therapy and PET scanner enhancements. High-Energy Physics: FPGA readout systems for ATLAS pixel detectors at CERN's Large Hadron Collider. AI Acceleration: Real-time machine learning inference for scientific applications via projects like hls4ml. His work bridges hardware innovation with computational physics, emphasizing real-time processing and low-latency systems. Publication Trends Recent research focuses on FPGA-accelerated machine learning for particle physics (e.g., transformer networks for LHC trigger systems) and quantum computing instrumentation. Earlier work established foundations in reconfigurable computing architectures and medical imaging electronics. Awards & Recognition Distinguished Teaching Award, University of Washington (2010) Advising & Funding Leads the ACME Lab with extensive funding from NSF, DARPA, NIH, DOE, and industry partners including Intel, Xilinx, and Microsoft. Mentored over 30 MS/PhD students in VLSI, reconfigurable systems, and scientific computing. Collaborations & Labs Directs the ACME Lab (EE1-307), collaborating with UW Radiology (Prof. Robert Miyaoka), UW Physics (Prof. Shih-Chieh Hsu), and Drexel University (Prof. Josh Agar). Projects include quantum control systems, LHC readout electronics, and medical sensor networks.
Rik Crutzen is a Full Professor at the Faculty of Health, Medicine and Life Sciences, Maastricht University, specializing in health promotion and digital interventions. His research focuses on leveraging technology to improve health behaviors across diverse populations, including adolescents, older adults, and immigrant communities. He leads projects in the CAPHRI research group for Promoting Health & Personalised Care. Research trends include: Digital health innovations (e.g., helplines, apps, algorithms) Chronic disease management (post-COVID-19, dementia risk) Health equity in immigrant populations (cervical cancer, maternal care) Behavioral interventions (physical activity, sleep, STI prevention) Systematic reviews and mixed-methods studies He has supervised 22 academic works and contributed to datasets on activity patterns and sleep-activity correlations. His work spans public health policy, health education, and technology integration.
Susan A. Murphy is the Mallinckrodt Professor of Statistics and of Computer Science at Harvard University, with affiliations to the Kempner Institute. She leads the Statistical Reinforcement Learning Lab, focusing on developing algorithms to inform sequential decision-making in health, particularly for Just-in-Time Adaptive Interventions (JITAIs) and micro-randomized trials (MRTs). Her work is funded by NIH institutes, including NIDA, NHLBI, and NIBIB. Dr. Murphy has been awarded a MacArthur Fellowship (2013) and is a member of the National Academy of Medicine (2014) and the National Academy of Sciences (2016). Her research integrates statistical methods with computer science techniques to optimize mobile health interventions. She collaborates with d3Lab and mDOT on projects like HeartSteps and Sense2Stop, evaluating real-time treatment policies. Notable contributions include advancing MRT designs, sample size calculations, and reinforcement learning algorithms for personalized healthcare. Dr. Murphy advises a large team of postdocs, graduate students, and undergraduates, many of whom hold academic and industry roles globally. She emphasizes engagement in digital interventions, balancing personalization with ethical considerations. Her lab’s work spans algorithm development, clinical trial design, and causal inference, aiming to improve health outcomes through adaptive interventions.
Britt Adamson is an Associate Professor in the Department of Molecular Biology and the Lewis-Sigler Institute for Integrative Genomics at Princeton University, where she serves as Director of the Undergraduate Program in Quantitative and Computational Biology. Her lab investigates molecular networks in human cells with focus on stress response mechanisms and genome editing technologies. She received her B.S. in Biology from the Massachusetts Institute of Technology (2005) and Ph.D. in Genetics and Genomics from Harvard University (2012), followed by postdoctoral training at UCSF under Jonathan Weissman supported by a Damon Runyon Cancer Research Foundation Fellowship. Adamson's research centers on how cells organize stress response networks during DNA damage and endoplasmic reticulum stress, developing CRISPR-based functional genomics and single-cell sequencing tools to map molecular behaviors. Her work bridges fundamental cell biology with therapeutic applications in genome editing. Analysis of her 15 most recent publications reveals dominant themes in precision genome editing (prime/base editing optimization) and systematic dissection of DNA repair pathways through combinatorial CRISPR screening. Her lab consistently integrates computational approaches with high-resolution experimental techniques to uncover context-dependent cellular behaviors. Her scientific recognitions include: Damon Runyon Cancer Research Foundation Postdoctoral Fellowship Princeton IP Accelerator Award (2025) STAT Who to Know: 10 Scientists leading a new generation of gene editors (2024) Adamson actively mentors eight graduate students (including alumni Ann Cirincione and Jun Hussmann) and two postdocs, with research funded through institutional awards and collaborative grants. Her lab's technological developments have enabled projects spanning virology, immunology, and developmental biology. The Adamson Lab operates within Princeton's Lewis-Sigler Institute for Integrative Genomics, fostering an interdisciplinary environment that merges cell biology, genomics, and computational science. Current projects focus on improving prime editing efficiency and understanding stress response adaptation in disease contexts.
Yvonne Rogers is a Professor of Interaction Design and Director of the UCL Interaction Centre (UCLIC), with a joint appointment as Deputy Head of the Department of Computer Science at University College London. She joined UCL in 2011 after holding professorships at the Open University (2006-2011) and Indiana University (2003-2006). Her pioneering work spans ubiquitous computing, interaction design, and human-computer interaction, with a current focus on human-centered AI. She co-authored the definitive 'Interaction Design' textbook (6 editions, 300,000+ copies) and serves as CTO of LetThink.com. Research interests center on designing technologies that enhance human cognition and daily activities: Ubiquitous Computing: Augmenting learning/work activities through pervasive technologies Human-AI Interaction: Developing AI systems that enhance human decision-making Health Technologies: Creating VR therapies and ADHD support systems Community Resilience: Designing tools for environmental monitoring and sustainable practices Publication analysis reveals three dominant trends: (1) VR applications for mental health (emotion regulation, ADHD support), (2) AI systems for cognitive augmentation, and (3) community-centered tools for healthcare/environmental challenges. Recent work demonstrates strong emphasis on vulnerable populations including children with ADHD, older adults, and postoperative patients. Major scientific recognition includes: International Member, National Academy of Engineering (2024) ACM SIGCHI Lifetime Research Award (2022) Royal Society Robin Milner Medal (2022) Royal Society Fellowship (2022) Microsoft Outstanding Collaborator Award MRC Suffrage and Science Award (2020) Triple Fellow status (ACM, BCS, CHI Academy) Advises PhD students including Leon Reicherts, Sheena Visram, and Tu Duong. Secured major grants including EPSRC Dream Fellowship on ageing/computing and led the Intel Collaborative Research Institute on Sustainable Connected Cities (2012-2018). Directs UCLIC research center and previously established the Pervasive Interaction Lab at Open University.
